As Cleerly expanded its AI research capability, it needed leadership capable of advancing both technology and clinical collaboration.
Recognising the strategic fit between the business and an exceptional AI leader, Wenham Carter made a targeted introduction that helped accelerate the company's next generation of cardiac imaging innovation.
Ceerly develops AI-powered software that helps clinicians diagnose and manage cardiovascular disease through advanced cardiac imaging.
As the business expanded its research and development capability, it was preparing to launch major collaborative programmes with leading US healthcare and research institutions, including Mayo Clinic. Strengthening AI leadership was central to those ambitions.
Cleerly was looking for someone capable of leading algorithm development, translating research into clinically deployable products, and building relationships across the academic and healthcare communities that would support future innovation.
Finding that combination of technical expertise, regulatory experience, and clinical credibility represented a highly specialist leadership challenge.
The appointment combined technical AI expertise, FDA experience, and established relationships across leading US healthcare institutions.
Over time, Wenham Carter had built a relationship with Naama, an accomplished AI leader whose experience spanned algorithm development, product deployment, and FDA-cleared medical imaging solutions. We also knew she was open to relocating internationally for the right executive opportunity.
Recognising the alignment between her experience and Cleerly’s ambitions, we introduced her directly to the company’s leadership team.
The discussions quickly demonstrated a strong strategic fit. Beyond her technical expertise, Naama brought established relationships with leading research institutions and key opinion leaders across the US cardiac imaging community, making her well positioned to support both product development and collaborative research initiatives.
Naama joined Cleerly as Director of AI Research & Development, relocating to New York to lead a new product workstream focused on expanding the company’s cardiac imaging capabilities.
Her appointment strengthened Cleerly’s AI leadership while supporting new collaborations with leading healthcare institutions and the development of next-generation diagnostic technologies. The role also positioned the business to broaden its product portfolio and reinforce its leadership in AI-driven cardiovascular imaging.
The appointment strengthened Cleerly's AI leadership while supporting new collaborations with leading healthcare institutions and the development of next-generation diagnostic technologies.
As Nuclivision prepared to commercialise its AI platform for nuclear medicine, it needed experienced regional leaders capable of introducing a new technology into one of healthcare's most specialist imaging markets.…
Following the appointment of a new CEO, Medis embarked on a broader commercial transformation to strengthen its leadership team and accelerate international growth. What began as a search for a…
Gero.AI, a biotech company rewriting human aging with physics and AI, has engaged an Advisor to support the company’s strategic growth and platform evolution. The Advisor will provide guidance on…
We organise our expertise around dynamic, global market ecosystems - rather than traditional industry silos – to see and seek connections others cannot.
Energy, Renewables & Natural Resources
Mobility & Transportation
Life Sciences
Industrial & Advanced Manufacturing
Space & Satellite
Technology & Communications
Professional & Technology Services
Financial Services
AI & Robotics
Defence & Security
Semiconductors & Advanced Materials
Venture Capital & Private Equity
Whether you need a CEO, a team rebuild, or a strategic introduction, we’re here to help. Our networks, experience and approach put the right connections within reach.
From in-orbit to in-vivo, we connect the right minds to move markets forward.
What expertise do you need?We track the forces rippling across industries and economies, spotting the first signs of what’s next so you are ready to act.
What's driving change in your business?We understand where you’re going and help you get there one person, team, partnership, or investment at a time.
What would help you go further?
